NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.48 Cr | ₹2.19 Cr | ₹1.37 Cr | ₹1.91 Cr | ₹2.38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹2.48 Cr |
| Mar2024 | ₹2.19 Cr |
| Mar2023 | ₹1.37 Cr |
| Mar2022 | ₹1.91 Cr |
| Mar2021 | ₹2.38 Cr |
How is Deferred Tax Assets / Liabilities of NGL FINECHEM Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.48 Cr | 12.85 | |
| Mar2024 | ₹2.19 Cr | 60.15 | |
| Mar2023 | ₹1.37 Cr | -28.20 | |
| Mar2022 | ₹1.91 Cr | -19.76 | |
| Mar2021 | ₹2.38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,470.1 Cr | 10.5% | -1.4% | 105.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 10.5% |
-1.4% |
105.7% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses